Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference

Paolo Giorgi Rossi, Francesca Carozzi, Antonio Federici, Guglielmo Ronco, Marco Zappa, Silvia Franceschi, Italian Screening in HPV vaccinated girls Consensus Conference group, Maria Lina Tornesello

Research output: Contribution to journalArticle

Abstract

In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in 2007/08 will reach the age (25years) for cervical cancer (CC) screening from 2017. The simultaneous shift from cytology-based screening to HPV test-based screening gives the opportunity for unprecedented reorganisation of CC prevention. The ONS (National Screening Monitoring Centre) Directive and the GISCi (Italian Group for Cervical Screening) identified the consensus conference as the most suitable method for addressing this topic. A summary of consensus recommendations is reported here. The main objective was to define the best screening methods in girls vaccinated against HPV and the knowledge required for defining evidence-based screening strategies. A Jury made recommendations about questions and proposals formulated by a panel of experts representative of Italian scientific societies involved in CC prevention and based on systematic reviews of literature and evidence. The Jury considered changing the screening protocols for girls vaccinated in their twelfth year as appropriate. Tailored screening protocols based on vaccination status could be replaced by "one size fits all" protocols only when a herd immunity effect has been reached. Vaccinated women should start screening at age 30, instead of 25, with HPV test. Furthermore, there is a strong rationale for applying longer intervals for re-screening HPV negative women than the currently recommended 5years, but research is needed to determine the optimal screening time points. For non-vaccinated women and for women vaccinated in their fifteenth year or later, the current protocol should be kept.

Original languageEnglish
Pages (from-to)21-30
Number of pages10
JournalPreventive Medicine
Volume98
DOIs
Publication statusPublished - May 2017

Fingerprint

Papillomavirus Infections
Early Detection of Cancer
Uterine Cervical Neoplasms
Vaccination
Herd Immunity
Italy
Cell Biology
Research

Keywords

  • Consensus
  • Early Detection of Cancer
  • Female
  • Humans
  • Italy
  • Papillomavirus Vaccines
  • Primary Prevention
  • Secondary Prevention
  • Uterine Cervical Neoplasms
  • Vaccination
  • Women's Health Services
  • Journal Article

Cite this

Cervical cancer screening in women vaccinated against human papillomavirus infection : Recommendations from a consensus conference. / Giorgi Rossi, Paolo; Carozzi, Francesca; Federici, Antonio; Ronco, Guglielmo; Zappa, Marco; Franceschi, Silvia; Italian Screening in HPV vaccinated girls Consensus Conference group ; Tornesello, Maria Lina.

In: Preventive Medicine, Vol. 98, 05.2017, p. 21-30.

Research output: Contribution to journalArticle

Giorgi Rossi, P, Carozzi, F, Federici, A, Ronco, G, Zappa, M, Franceschi, S, Italian Screening in HPV vaccinated girls Consensus Conference group & Tornesello, ML 2017, 'Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference', Preventive Medicine, vol. 98, pp. 21-30. https://doi.org/10.1016/j.ypmed.2016.11.020
Giorgi Rossi, Paolo ; Carozzi, Francesca ; Federici, Antonio ; Ronco, Guglielmo ; Zappa, Marco ; Franceschi, Silvia ; Italian Screening in HPV vaccinated girls Consensus Conference group ; Tornesello, Maria Lina. / Cervical cancer screening in women vaccinated against human papillomavirus infection : Recommendations from a consensus conference. In: Preventive Medicine. 2017 ; Vol. 98. pp. 21-30.
@article{68b95dee42694125ba1f230a0ff2fdd7,
title = "Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference",
abstract = "In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in 2007/08 will reach the age (25years) for cervical cancer (CC) screening from 2017. The simultaneous shift from cytology-based screening to HPV test-based screening gives the opportunity for unprecedented reorganisation of CC prevention. The ONS (National Screening Monitoring Centre) Directive and the GISCi (Italian Group for Cervical Screening) identified the consensus conference as the most suitable method for addressing this topic. A summary of consensus recommendations is reported here. The main objective was to define the best screening methods in girls vaccinated against HPV and the knowledge required for defining evidence-based screening strategies. A Jury made recommendations about questions and proposals formulated by a panel of experts representative of Italian scientific societies involved in CC prevention and based on systematic reviews of literature and evidence. The Jury considered changing the screening protocols for girls vaccinated in their twelfth year as appropriate. Tailored screening protocols based on vaccination status could be replaced by {"}one size fits all{"} protocols only when a herd immunity effect has been reached. Vaccinated women should start screening at age 30, instead of 25, with HPV test. Furthermore, there is a strong rationale for applying longer intervals for re-screening HPV negative women than the currently recommended 5years, but research is needed to determine the optimal screening time points. For non-vaccinated women and for women vaccinated in their fifteenth year or later, the current protocol should be kept.",
keywords = "Consensus, Early Detection of Cancer, Female, Humans, Italy, Papillomavirus Vaccines, Primary Prevention, Secondary Prevention, Uterine Cervical Neoplasms, Vaccination, Women's Health Services, Journal Article",
author = "{Giorgi Rossi}, Paolo and Francesca Carozzi and Antonio Federici and Guglielmo Ronco and Marco Zappa and Silvia Franceschi and {Italian Screening in HPV vaccinated girls Consensus Conference group} and Tornesello, {Maria Lina}",
note = "Copyright {\circledC} 2016 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2017",
month = "5",
doi = "10.1016/j.ypmed.2016.11.020",
language = "English",
volume = "98",
pages = "21--30",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Cervical cancer screening in women vaccinated against human papillomavirus infection

T2 - Recommendations from a consensus conference

AU - Giorgi Rossi, Paolo

AU - Carozzi, Francesca

AU - Federici, Antonio

AU - Ronco, Guglielmo

AU - Zappa, Marco

AU - Franceschi, Silvia

AU - Italian Screening in HPV vaccinated girls Consensus Conference group

AU - Tornesello, Maria Lina

N1 - Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2017/5

Y1 - 2017/5

N2 - In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in 2007/08 will reach the age (25years) for cervical cancer (CC) screening from 2017. The simultaneous shift from cytology-based screening to HPV test-based screening gives the opportunity for unprecedented reorganisation of CC prevention. The ONS (National Screening Monitoring Centre) Directive and the GISCi (Italian Group for Cervical Screening) identified the consensus conference as the most suitable method for addressing this topic. A summary of consensus recommendations is reported here. The main objective was to define the best screening methods in girls vaccinated against HPV and the knowledge required for defining evidence-based screening strategies. A Jury made recommendations about questions and proposals formulated by a panel of experts representative of Italian scientific societies involved in CC prevention and based on systematic reviews of literature and evidence. The Jury considered changing the screening protocols for girls vaccinated in their twelfth year as appropriate. Tailored screening protocols based on vaccination status could be replaced by "one size fits all" protocols only when a herd immunity effect has been reached. Vaccinated women should start screening at age 30, instead of 25, with HPV test. Furthermore, there is a strong rationale for applying longer intervals for re-screening HPV negative women than the currently recommended 5years, but research is needed to determine the optimal screening time points. For non-vaccinated women and for women vaccinated in their fifteenth year or later, the current protocol should be kept.

AB - In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in 2007/08 will reach the age (25years) for cervical cancer (CC) screening from 2017. The simultaneous shift from cytology-based screening to HPV test-based screening gives the opportunity for unprecedented reorganisation of CC prevention. The ONS (National Screening Monitoring Centre) Directive and the GISCi (Italian Group for Cervical Screening) identified the consensus conference as the most suitable method for addressing this topic. A summary of consensus recommendations is reported here. The main objective was to define the best screening methods in girls vaccinated against HPV and the knowledge required for defining evidence-based screening strategies. A Jury made recommendations about questions and proposals formulated by a panel of experts representative of Italian scientific societies involved in CC prevention and based on systematic reviews of literature and evidence. The Jury considered changing the screening protocols for girls vaccinated in their twelfth year as appropriate. Tailored screening protocols based on vaccination status could be replaced by "one size fits all" protocols only when a herd immunity effect has been reached. Vaccinated women should start screening at age 30, instead of 25, with HPV test. Furthermore, there is a strong rationale for applying longer intervals for re-screening HPV negative women than the currently recommended 5years, but research is needed to determine the optimal screening time points. For non-vaccinated women and for women vaccinated in their fifteenth year or later, the current protocol should be kept.

KW - Consensus

KW - Early Detection of Cancer

KW - Female

KW - Humans

KW - Italy

KW - Papillomavirus Vaccines

KW - Primary Prevention

KW - Secondary Prevention

KW - Uterine Cervical Neoplasms

KW - Vaccination

KW - Women's Health Services

KW - Journal Article

U2 - 10.1016/j.ypmed.2016.11.020

DO - 10.1016/j.ypmed.2016.11.020

M3 - Article

C2 - 27894910

VL - 98

SP - 21

EP - 30

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -